VSEE HEALTH INC
VSEENASDAQTrading Snapshot
- Day Range
- $1.67 β $1.71
- 52-Week Range
- $0.42 β $201.60
- Volume
- $3.22B
- Avg Volume
- $3.93B
- Shares Outstanding
- 55.7M
- Next Earnings
- Oct 19, 2026
Fundamentals Snapshot
- Annual Revenue
- $15M
- Last Q Revenue
- $2M
- P/E Ratio
- β
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-0.48
- Dividend Yield
- β
- Dilution (1yr)
- +27.5%
Why Investors Own VSEE
- βHigh-growth profile β revenue up +2.4% YoY with expanding US Equity exposure.
- βHealthy economics β 59% gross margin and 16% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
VSEE HEALTH INC
VSEEAbout VSEE HEALTH INC
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

VSee Health Poised for Growth
VSee Health announces Annual Meeting Results HOUSTON, TX / ACCESS Newswire / August 27, 2026 / VSee Health, Inc. (NASDAQ:VSEE) (the "Company"), a provider of telehealth services and technology, announced that it has iden

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings
The acquisition is expected to close fairly quickly and without any initial shareholder dilution HOUSTON, TX / ACCESS Newswire / July 30, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provid

VSEE Vertically Integrated Healthcare Commerce Platform
Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earnings HOUSTON, TX / ACCESS Newswire / July 29, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" o

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has in

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution
HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shar

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations
VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of en